RedHill Biopharma (RDHL) Change in Cash (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Change in Cash of $4.8 million for Q4 2022, down 23.04% year-over-year from $6.2 million in Q4 2021, and up 140.61% quarter-over-quarter from -$11.8 million in Q3 2022.
RedHill Biopharma (RDHL) Change in Cash (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Change in Cash for 11 consecutive years, with $4.8 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Change in Cash fell 23.04% year-over-year to $4.8 million; the TTM figure through Dec 2022 stood at -$9.4 million (down 3516.67% YoY), while the FY2025 annual figure was -$644000.0, up 32.99% from the prior year.
- Change in Cash improved to $4.8 million in Q4 2022 per RDHL's latest filing, from -$11.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $52.5 million in Q1 2020 and bottomed at -$59.4 million in Q2 2020.
- Historically, Change in Cash has averaged $178300.0 across 5 years, with a median of $1.0 million in 2019.
- Annual changes were most pronounced in 2020 — Change in Cash jumped 973.31% — and 2021, when it plunged 821.02%.
- RedHill Biopharma's Change in Cash stood at $10.3 million in 2018, then soared by 67.7% to $17.3 million in 2019, then plunged by 82.19% to $3.1 million in 2020, then surged by 101.13% to $6.2 million in 2021, then fell by 23.04% to $4.8 million in 2022.
- Business Quant data shows RDHL's Change in Cash at $4.8 million in Q4 2022, -$11.8 million in Q3 2022, and -$1.8 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.78 Mn |
| Sep 30, 2022 | -11.77 Mn |
| Jun 30, 2022 | -1.83 Mn |
| Mar 31, 2022 | -612,000.00 |
| Dec 31, 2021 | 6.21 Mn |
| Sep 30, 2021 | -28.55 Mn |
| Jun 30, 2021 | -24.17 Mn |
| Mar 31, 2021 | 46.78 Mn |
| Dec 31, 2020 | 3.09 Mn |
| Sep 30, 2020 | 3.96 Mn |
| Jun 30, 2020 | -59.37 Mn |
| Mar 31, 2020 | 52.46 Mn |
| Dec 31, 2019 | 17.34 Mn |
| Sep 30, 2019 | 2.64 Mn |
| Jun 30, 2019 | -14.04 Mn |
| Mar 31, 2019 | -6.01 Mn |
| Dec 31, 2018 | 10.34 Mn |
| Sep 30, 2018 | 13.14 Mn |
| Jun 30, 2018 | -1.94 Mn |
| Mar 31, 2018 | -8.88 Mn |